Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
CNS Disease
What activity restrictions do you counsel patients on after radiosurgery for arteriovenous malformations, given the continued risk of hemorrhage until nidus obliteration?
Related Questions
Do you routinely prescribe memantine for patients who will be receiving hippocampal sparing whole brain RT if they are already on donepezil, or is donepezil alone sufficient?
What would be your approach in a patient who presented with a solitary brain metastasis that resolved after chemo without local therapy?
What ipsilateral lung constraints if any do you utilize for SBRT and or hypofractionated RT in the lungs?
What experience do you have with paralysis or myasthenia like symptoms developing on Temozolomide?
What hotspot and heterogeneity metrics do you utilize when delivering PMRT to a patient who has had breast reconstruction?
Under what circumstances would you offer PMRT in a patient with DCIS?
How would you treat a stage IIA NS HD patient with bulky disease who refuses chemotherapy?
What are your top takeaways from SGO 2024?
Do you offer prostate RT to men with 0-3 bone metastases on conventional imaging when PSMA PET shows a very high number of M1 lesions?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?
